• Chlorpromazine, Urine
  • Myelodysplastic Syndrome (MDS), Flow Cytometry, Bone Marrow
  • Tissue Transglutaminase (tTG) Antibody, IgA, IgG
  • Rocky mountain spotted fever
  • Mycoplasma pneumoniae, Culture
  • Spectrumâ„¢ Pre-implantation Genetic Testing
  • Infection by Trypanosoma cruzi (Chaga's Disease)
  • Clostridium difficile infection
  • HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity
  • Metabolic alkalosis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Reference Ranges
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.
Loading...